Showing results 4 to 5 of 5
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial Journal:The Lancet Gastroenterology & Hepatology | 2016 | ||
2016 |